Clinical trials
Completed trials in Serbia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 9 |
| 2014 | 9 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 11 |
| 2019 | 9 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 8 |
| 2023 | 13 |
| 2024 | 8 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 122 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Novi Sad, Faculty of Sport and Physical Education | 20 |
| University of Belgrade | 16 |
| University of Novi Sad | 9 |
| Medtronic Cardiac Rhythm and Heart Failure | 5 |
| Clinical Centre of Serbia | 4 |
| Smith & Nephew, Inc. | 4 |
| Center for Health Sciences, Serbia | 3 |
| Clinical Hospital Center Zemun | 2 |
| HiPP GmbH & Co. Vertrieb KG | 2 |
| Rasa Mladenovic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 8 |
| Fatigue | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| ST Elevation Myocardial Infarction | 3 |
| Angina Pectoris | 2 |
| Angina, Stable | 2 |
| Aortic Aneurysm, Abdominal | 2 |
| Aortic Valve Stenosis | 2 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.